Anti-NDST3 monoclonal antibody
Pre-made anti-NDST3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to NDST3/NDST3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1250-Ab-1/ GM-Tg-hg-IP1250-Ab-2 | Anti-Human NDST3 monoclonal antibody | Human |
GM-Tg-rg-IP1250-Ab-1/ GM-Tg-rg-IP1250-Ab-2 | Anti-Rat NDST3 monoclonal antibody | Rat |
GM-Tg-mg-IP1250-Ab-1/ GM-Tg-mg-IP1250-Ab-2 | Anti-Mouse NDST3 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1250-Ab-1/ GM-Tg-cynog-IP1250-Ab-2 | Anti-Cynomolgus/ Rhesus macaque NDST3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1250-Ab-1/ GM-Tg-felg-IP1250-Ab-2 | Anti-Feline NDST3 monoclonal antibody | Feline |
GM-Tg-cang-IP1250-Ab-1/ GM-Tg-cang-IP1250-Ab-2 | Anti-Canine NDST3 monoclonal antibody | Canine |
GM-Tg-bovg-IP1250-Ab-1/ GM-Tg-bovg-IP1250-Ab-2 | Anti-Bovine NDST3 monoclonal antibody | Bovine |
GM-Tg-equg-IP1250-Ab-1/ GM-Tg-equg-IP1250-Ab-2 | Anti-Equine NDST3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1250-Ab-1/ GM-Tg-hg-IP1250-Ab-2; GM-Tg-rg-IP1250-Ab-1/ GM-Tg-rg-IP1250-Ab-2; GM-Tg-mg-IP1250-Ab-1/ GM-Tg-mg-IP1250-Ab-2; GM-Tg-cynog-IP1250-Ab-1/ GM-Tg-cynog-IP1250-Ab-2; GM-Tg-felg-IP1250-Ab-1/ GM-Tg-felg-IP1250-Ab-2; GM-Tg-cang-IP1250-Ab-1/ GM-Tg-cang-IP1250-Ab-2; GM-Tg-bovg-IP1250-Ab-1/ GM-Tg-bovg-IP1250-Ab-2; GM-Tg-equg-IP1250-Ab-1/ GM-Tg-equg-IP1250-Ab-2 |
Products Name | Anti-NDST3 monoclonal antibody |
Format | mab |
Target Name | NDST3 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-NDST3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1250-Ag-1 | Recombinant multi-species NDST3/ HSST3 protein |
Target information
Target ID | GM-IP1250 |
Target Name | NDST3 |
Gene ID | 9348,295430,704244,487918,101095009 |
Gene Symbol and Synonyms | HSST3,NDST3 |
Uniprot Accession | O95803 |
Uniprot Entry Name | NDST3_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000164100 |
Target Classification | N/A |
The target: NDST3, gene name: NDST3, also named as HSST3. This gene encodes a member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family. The encoded enzyme is a type II transmembrane protein that resides in the Golgi apparatus. This monomeric bifunctional enzyme catalyzes the N-deacetylation and N-sulfation of N-acetylglucosamine residues in heparan sulfate and heparin, which are the initial chemical modifications required for the biosynthesis of the functional oligosaccharide sequences that define the specific ligand binding activities of heparan sulfate and heparin. [provided by RefSeq, Nov 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.